DCAT Value Chain Insights’ Production to Prescription
By DCAT
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by DCAT
Category: Business
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 58
Description
DCAT Value Chain Insights' Production to Prescription podcast, presented by the Drug, Chemical & Associated Technologies Association (DCAT), features thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance.
| Episode | Date |
|---|---|
|
CDMO Outlook: Small Molecules—What Lies Ahead?
|
Jun 04, 2026 |
|
A CDMO Roundtable: The Making of a Molecule: Peptide Synthesis
|
May 14, 2026 |
|
What Tops the Industry’s Sustainability Agenda for 2026?
|
Mar 05, 2026 |
|
2026 Outlook: CDMO Market for Injectables
|
Feb 05, 2026 |
|
2026: Drugs To Watch: The Year Ahead
|
Jan 15, 2026 |
|
2025: The Bio/Pharma Industry’s Year in Review
|
Dec 11, 2025 |
|
What’s Trending: ADCs: Pipelines, Products, & CDMO Growth
|
Nov 06, 2025 |
|
Drug Launches & Approvals in 2025: The Blockbuster Contenders
|
Oct 16, 2025 |
|
CDMOs-Injectables: Tariff Impact: Are Capacity Shifts in the Making?
|
Sep 04, 2025 |
|
Headwinds or Tailwinds: Will the Biotech Sector Rebound in 2025?
|
Jun 05, 2025 |
|
Global API Outlook: Will Supply Lines Change Amid Tariff Uncertainty?
|
May 08, 2025 |
|
Biomanufacturing: How are Industry Capacity & Supply Chains Trending?
|
Apr 03, 2025 |
|
Parenteral Drug Mfg—CDMO Outlook: a Capacity Crunch of Easing?
|
Feb 06, 2025 |
|
Bio/Pharma Industry Outlook, Supply Chains 2025: The Year Ahead
|
Dec 30, 2024 |
|
What’s Trending: Parenteral Drug Development & Manufacturing
|
Feb 22, 2024 |
|
CDMOs/CMOs: The Movers and Shakers of 2023
|
Dec 21, 2023 |
|
CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023
|
Jun 14, 2023 |
|
API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains
|
May 02, 2023 |
|
The CDMO/CMO Report: Parenteral Drugs
|
Nov 16, 2022 |
|
Drug Products: Key Trends & Recent Approvals
|
Aug 17, 2022 |
|
CDMOs/CMOs Expand High-Potency API Manufacturing
|
Jul 14, 2022 |
|
Incorporating Sustainability into the Bio/Pharma Supply Chain: Where Does the Industry Stand?
|
Mar 31, 2022 |
|
CDMOs/CMOs Ramp Up Biomanufacturing Capacity
|
Mar 14, 2022 |
|
How Can Today’s Supply-Chain Challenges Be Fixed?
|
Mar 07, 2022 |
|
Parenteral Drugs: CDMOs/CMOs Expanding
|
Nov 15, 2021 |
|
Rising Energy Costs and API Supply
|
Oct 25, 2021 |
|
Blockbuster Muscle: Small Molecules or Biologics?
|
Sep 07, 2021 |
|
Injectable and Solid Dosage Drug Delivery: Key Deals
|
Aug 13, 2021 |
|
Mid-Year CDMO Review: COVID-19 Vaccine Manufacturing and M&A
|
Jun 11, 2021 |
|
FDA Addresses Supply Constraints Due to COVID-19; Plus, Packaging Suppliers Expand
|
Mar 12, 2021 |
|
The Year in Review: 2020
|
Dec 04, 2020 |
|
Company on the Move: Viatris
|
Nov 20, 2020 |
|
Solid-Dosage Mfg: CDMO Market and Product Trends
|
Nov 05, 2020 |
|
Top 10 Watch List: Pharma CEOs on the Rise
|
Oct 23, 2020 |
|
The Pipeline Contenders: What Drugs Are Making the Mark?
|
Oct 09, 2020 |
|
Injectable Drugs: CDMOs/CMOs and Suppliers Expand
|
Sep 18, 2020 |
|
API Watch: Small Molecules
|
Sep 04, 2020 |
|
The Top 10 Deals for Pharma Innovation
|
Aug 24, 2020 |
|
Novel Excipients: Gaining Traction in the Industry
|
Aug 10, 2020 |
|
Re-configuring Global Pharma Supply Chains
|
Jul 10, 2020 |
|
2020 Vision: Digital Pharma—Beyond the Pill
|
Jun 29, 2020 |
|
A Top 10 Emerging Pharma Watch List
|
Jun 22, 2020 |
|
CDMOs Step Up to the COVID Challenge but Must Prepare for Uncertain Future
|
Jun 11, 2020 |
|
Tracking Expansion in High-Potency Manufacturing
|
Jun 04, 2020 |
|
DCAT Benchmarking Study Provides Insight into Supply-Chain Challenges
|
May 28, 2020 |
|
Pharma Company on the Move: The New AbbVie
|
May 22, 2020 |
|
Re-inventing US Pharma Mfg and Supply Chains
|
May 15, 2020 |
|
Supplying Potential COVID-19 Treatments & Vaccines
|
May 13, 2020 |
|
Drug Development in Wake of COVID-19
|
May 01, 2020 |
|
A Top 10 Watch List: Biologics and Biomanufacturing
|
Apr 27, 2020 |
|
Facilitating Sourcing in the Wake of COVID-19
|
Apr 17, 2020 |
|
COVID-19's Impact on Global Pharma Supply Chains
|
Apr 06, 2020 |
|
Indian Government Looks to Increase Domestic API Manufacturing
|
Mar 27, 2020 |
|
Drug Supply Chains and US-Based Manufacturing
|
Mar 23, 2020 |
|
Blockbuster Watch for 2020: New Market Entrants
|
Mar 03, 2020 |
|
Orphan Drugs: Bearing Revenue Gains or Not?
|
Feb 25, 2020 |
|
Emerging Biopharma Companies: Tracking Their Contribution to Innovation
|
Feb 14, 2020 |
|
20-20 Insights and Outlook for the CDMO Market
|
Feb 14, 2020 |